Skip to content

Comparison of nerveblock and local infiltration block in the knee after total knee replacement.

Comparison of femoral nerve block with posterior capsule infiltration versus anterior and posterior capsule infiltration after total knee replacement. - LiFeAnKeR

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-005596-90-NL
Enrollment
Unknown
Registered
2015-04-21
Start date
2015-04-22
Completion date
Unknown
Last updated
2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patienst requiring total knee replacement for non-inflammatory osteoarthritis of the knee

Interventions

Trade Name: ropivacaine HCl Pharmaceutical Form: Solution for injection INN or Proposed INN: ropivacaine CAS Number: 132112-35-7 Current Sponsor code: non Other descriptive name: ROPIVACAINE HYDROCHLO

Sponsors

St. Lucas Andreas Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients 18 years and older who are scheduled for a TKA with spinal anesthesia. - age above 18 years - mentally competent - eligible for TKA - informed consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 60

Exclusion criteria

Exclusion criteria: -contra indication for spinal anesthesia (severe aortic stenosis, severely compromised cardiac function) - infection at interspace of spinal injection - allergy to used medicine - repeat TKA - all previous surgeries concerning arthrotomy - participation in other research protocol

Design outcomes

Primary

MeasureTime frame
Main Objective: Identifying the optimal analgesia technique for patients undergoing a total knee replacement giving the best functional outcome.;Secondary Objective: - NRS pain score in rest from the day of surgery until day 3 post surgery - NRS pain score in flexion exercise from the day of surgery until day 3 post surgery - NRS pain score postoperatively when walking - range of motion with flexion and extension during 3 postoperative days - length of stay in hospital - side-effects;Primary end point(s): -Opioid consumption measured by mg of morphine i.v. used daily (every morning at 10.00 am) -Mobilization measured by Modified Iowa Levels of Assistance Scale (MILAS);Timepoint(s) of evaluation of this end point: day of surgery, postoperative during hospital stay

Secondary

MeasureTime frame
Secondary end point(s): - NRS pain score in rest from the day of surgery until day 3 post surgery - NRS pain score in flexion exercise from the day of surgery until day 3 post surgery - NRS pain score postoperatively when walking - range of motion with flexion and extension during 3 postoperative days - length of stay in hospital - side-effects;Timepoint(s) of evaluation of this end point: day of operation, postoperative during hospital stay

Countries

Netherlands

Contacts

Public ContactAnesthesiology

St. Lucas Andreas Hospital

m.vogel@slaz.nl0031020510 8911

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026